JESSICA SHABO: Open Payments
NPI 1275869612 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 16 payments from 11 companies in 2025. Trend: 2023 $323 · 2024 $192 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 4 | $56 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Tris Pharma Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Alkermes, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: Azstarys, Auvelity, Dyanavel XR, REXULTI, SPRAVATO, FANAPT, CAPLYTA, COBENFY.
Industry payments across NJ — which companies pay providers there.
